Epigenetic Regulation of the Nitric Oxide Pathway, 17-α Hydroxyprogesterone Caproate, and Recurrent Preterm Birth.

about

Epigenetic Regulation of the Nitric Oxide Pathway, 17-α Hydroxyprogesterone Caproate, and Recurrent Preterm Birth.

Item

http://www.wikidata.org/entity/Q47249385

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Epigenetic Regulation of the N ...... , and Recurrent Preterm Birth.

@en

Epigenetic Regulation of the N ...... , and Recurrent Preterm Birth.

@nl

type

Item

label

Epigenetic Regulation of the N ...... , and Recurrent Preterm Birth.

@en

Epigenetic Regulation of the N ...... , and Recurrent Preterm Birth.

@nl

prefLabel

Epigenetic Regulation of the N ...... , and Recurrent Preterm Birth.

@en

Epigenetic Regulation of the N ...... , and Recurrent Preterm Birth.

@nl

P1476

Epigenetic Regulation of the N ...... e, and Recurrent Preterm Birth

@en

P2093

Christina Smith

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Martin

http://www.w3.org/2001/XMLSchema#string

Lisa Smeester

http://www.w3.org/2001/XMLSchema#string

Martha S Tomlinson

http://www.w3.org/2001/XMLSchema#string

Michael W Varner

http://www.w3.org/2001/XMLSchema#string

Tracy A Manuck

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

Crucial role of peroxiredoxin III in placental antioxidant defense of mice

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Time course analysis of RNA stability in human placenta.

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.

Uterine FK506-binding protein 52 (FKBP52)-peroxiredoxin-6 (PRDX6) signaling protects pregnancy from overt oxidative stress.

Agonist-specific compartmentation of cGMP action in myometrium.

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease.

P304

721-728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0037-1613682

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rebecca C Fry

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29241278

http://www.w3.org/2001/XMLSchema#string

P932

6002888

http://www.w3.org/2001/XMLSchema#string